Bunge Global SA
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-04-29.
0001628280-26-028235
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-07-29.
0001628280-26-050540
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 8 previous paragraphs and 11 current paragraphs.
7 unchanged; 0 reworded; 4 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (4)
Current report
Issuer Purchases of Equity Securities
Current report
The following table is a summary of purchases of equity securities during the second quarter of 2026 by Bunge and any of its affiliated purchasers, pursuant to SEC rules.
Current report
(1)Program was authorized for the repurchase of up to $2.7 billion issued and outstanding registered shares. The program had an indefinite term. Total repurchases under the program from inception through June 30, 2026 were 28,383,187 shares for $2.7 billion, thereby completing the program.
Current report
(2)A new program was approved by Bunge's Board of Directors effective March 9, 2026, for the repurchase of up to $3.0 billion issued and outstanding registered shares. The program has an indefinite term.